bylieve study results: alpelisib and endocrine therapy in patients with pik3ca-mutated/hr /her2-...
Published 5 years ago • 2.2K plays • Length 3:53Download video MP4
Download video MP3
Similar videos
-
3:07
bylieve study cohort a: alpelisib et in pik3ca-mutant, hr , her2-, advanced breast cancer
-
3:01
bylieve additional cohort: update on the trial of alpelisib in advanced breast cancer from esmo
-
6:42
alpelisib plus fulvestrant for advanced breast cancer: subgroup analyses from the phase iii sola...
-
10:23
sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment o...
-
5:42
results of the belle-3 study of buparlisib for advanced breast cancer
-
7:49
asco: alpelisib plus fulvestrant for pik3ca-mutated breast cancer after failure of cdk4/6 inhibitors
-
5:14
adding alpelisib for hr /her2- advanced breast cancer in solar-1: adverse event impacts
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
4:11
ribociclib plus endocrine therapy improves survival in premenopausal patients with metastatic br...
-
5:57
alpelisib in the management of pik3ca-mutated breast cancer
-
4:53
alpelisib and fulvestrant for advanced breast cancer: solar-1
-
12:58
update on pik3ca inhibitor (alpelisib) in lymphatic anomalies
-
1:05
epik-p1 study: alpelisib for pik3ca-related overgrowth spectrum disorders
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
2:37
common breast cancer drug alpelisib may have an alarming side effect, finds study
-
4:35
os results from solar-1 trial of alpelisib reported | fabrice andré
-
3:27
alpelisib plus fulvestrant for hormone receptor positive metastatic breast cancer
-
4:48
alpelisib and t-dm1 for her2-positive metastatic breast cancer
-
2:09:26
pik3ca mutation breast cancer hr her- alpelisib